Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Safety and Effectiveness Study of the Zenflow Spring System
- Conditions
- BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms (LUTS)
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Zenflow, Inc.
- Target Recruit Count
- 279
- Registration Number
- NCT04987138
- Locations
- 🇺🇸
American Institute of Research, Los Angeles, California, United States
🇺🇸Northshore University Health System, Glenview, Illinois, United States
🇺🇸Sheldon Freedman, MD, LTD, Las Vegas, Nevada, United States
The Zenflow Spring System Safety and Performance Study (ZEST CAN)
- Conditions
- Benign Prostatic Hyperplasia
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Zenflow, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04309695
- Locations
- 🇨🇦
Toronto Western Hospital, Toronto, ONT, Canada
🇨🇦Groupe Sante Brunswick, Pointe-Claire, Quebec, Canada
The Zenflow Spring System Safety, Performance and Effectiveness Study
- Conditions
- Benign Prostatic Hyperplasia
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Zenflow, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03595735
- Locations
- 🇲🇽
Hospital Regional de Alta Especialidad de Ixtapaluca, Zoquiapan, Ciudad de Ixtapaluca, Mexico
🇲🇽Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, Mexico
🇲🇽Centro de Urología Avanzada del Noreste (CUAN), Monterrey, Nuevo León, Mexico
The Zenflow Spring System EU Safety and Performance Study
- Conditions
- Benign Prostatic Hyperplasia
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Zenflow, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT03577236
- Locations
- 🇦🇺
Australian Clinical Trials, Wahroonga, New South Wales, Australia
🇦🇺South Coast Urology, Wollongong, New South Wales, Australia
🇦🇺Goldfields Urology, Bendigo, Victoria, Australia
The Zenflow Spring System Feasibility and Safety Study
- Conditions
- Benign Prostatic Hyperplasia
- First Posted Date
- 2016-05-30
- Last Posted Date
- 2019-02-06
- Lead Sponsor
- Zenflow, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02786290
- Locations
- 🇧🇬
MBAL "Tokuda Bolnitsa Sofia" AD, Sofia, Bulgaria
🇳🇿RoundHay Medical Center, Nelson South, Nelson, New Zealand
🇳🇿Tauranga Urology Research Ltd, Tauranga, New Zealand